Heart Failure & Device Therapy

A New Era in Heart Failure Management: Improving Outcomes with Emerging Technologies and Collaborative Care Strategies
Identify the incidence, prevalence, morbidity, mortality and cost of heart failure. Assess current heart failure guidelines and classifications. Evaluate existing and emerging therapeutic strategies and interdisciplinary collaborative approaches for the management of heart failure. Discuss the applications of device based diagnostics for heart failure monitoring.

Changing the Landscape of Heart Failure Management
Review the most common symptoms leading to heart failure hospitalization. Evaluate advances in hemodynamic monitoring and its role for improving outcomes in heart failure patients.

Clinician Response to Remote Active Monitoring in Patients with Heart Failure: Results of the RAPID-RF Trial
Advances in remote patient monitoring (RPM) technologies enable automatic wireless transmission of radiofrequency (RF)-enabled implantable device and physiologic data that may allow for more frequent and flexible treatment regimens. We evaluated physician therapeutic interventions in response to daily remote device transmissions and weight measures in heart failure patients after cardiac resynchronization therapy defibrillator (CRT-D) implant. – See more at: http://www.innovationsincrm.com/cardiac-rhythm-management/2014/march/568-results-of-the-rapid-rf-trial#sthash.rjt2NOrs.dpuf

Heart Failure: Interventions to Reduce Morbidity, Mortality, and Hospitalizations
The goal of this activity is to update clinicians’ awareness of management techniques to address the risks of decompensation and sudden cardiac arrest in patients with heart failure.

ICD Shock Reduction: Update on Economic Impact and Therapeutic Options – Webinar
Its a fact: ICD shocks save lives. But at what cost? The clinical, psychological, and economic health care utilization implications of inappropriate and unnecessary shocks are just presently beginning to emerge. Join key opinion leaders Bruce Wilkoff, MD, FHRS and Mintu Turakhia, MD, MS, FHRS for this 30-minute webinar to get the most up-to-date information on this developing topic.

Live End Stage Heart Failure: Managing Complex Arrhythmias in the Complex Patient
To explain the indication for device therapy in advanced heart failure patients. To explain the CIED programming considerations in the LVAD patient. To identify treatment options including pharmacologic and ablative strategies.

Prevention of Sudden Cardiac Arrest Post PTCA in High-Risk Patients CME
The goal of this activity is to enhance the ability to protect patients at high risk for sudden cardiac death immediately after percutaneous coronary intervention without using inappropriate implantable cardioverter-defibrillator therapy. Upon completion of this activity, participants will be able to: 1.Define the risk for sudden cardiac arrest (SCA) following percutaneous transluminal coronary angioplasty (PTCA), especially in patients at high risk 2.Assess the role of wearable defibrillators in the management of patients at risk for SCA following PTCA 3.Implement optimal strategies to reduce the risk for SCA post PTCA at the time of hospital discharge